Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOPIDOGREL BISULFATE vs NILOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLOPIDOGREL BISULFATE vs NILOTINIB: Safety Overview

Metric CLOPIDOGREL BISULFATE NILOTINIB
Total FAERS Reports 46,012 23,171
Deaths Reported 5,327 4,543
Death Rate 11.6% 19.6%
Hospitalizations 24,774 4,846
Average Patient Age 70.0 yrs 56.5 yrs
% Female Patients 41.2% 47.7%
FDA Approval Date Apr 11, 2014 Dec 15, 2025
Manufacturer Major Pharmaceuticals Novadoz Pharmaceuticals LLC
Route ORAL ORAL
Marketing Status Prescription Prescription